Intravenous injection of apoA-V reconstituted HDL decreases hypertriglyceridemia in apoav-/- mice and requires GPIHBP1

Antzeko izenburuak

• Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
  nork: Valanti, Eftaxia-Konstantina, et al.
  Argitaratua: (2018)
• Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
  nork: Zhong, S, et al.
  Argitaratua: (1994)
• Different Functional and Structural Characteristics between ApoA-I and ApoA-4 in Lipid-Free and Reconstituted HDL State: ApoA-4 Showed Less Anti-Atherogenic Activity
  nork: Yoo, Jeong-Ah, et al.
  Argitaratua: (2015)
• HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
  nork: Chyu, Kuang-Yuh, et al.
  Argitaratua: (2015)
• Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux
  nork: Daniil, Georgios, et al.
  Argitaratua: (2013)